Hdfc Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 27-04-2026
NAV ₹18.27(R) +2.31% ₹18.84(D) +2.33%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 12.86% -% -% -% -%
Direct 14.2% -% -% -% -%
Nifty Pharma TRI 6.53% 23.67% 12.57% 14.52% 8.22%
SIP (XIRR) Regular 14.48% -% -% -% -%
Direct 15.81% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 1976 Cr

NAV Date: 27-04-2026

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 18.27
0.4100
2.3100%
HDFC Pharma and Healthcare Fund - Growth Option 18.27
0.4100
2.3100%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 18.84
0.4300
2.3300%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 18.84
0.4300
2.3300%

Review Date: 27-04-2026


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 6.26 2.69
5.42
2.60 | 7.15 5 | 16 Good
3M Return % 11.11 6.59
8.12
4.25 | 11.19 2 | 16 Very Good
6M Return % 5.68 4.11
0.40
-2.94 | 5.68 1 | 16 Very Good
1Y Return % 12.86 6.53
6.10
1.55 | 12.86 1 | 15 Very Good
1Y SIP Return % 14.48
5.47
-12.79 | 14.48 1 | 15 Very Good
Return data last Updated On : April 27, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 6.37 2.69 5.54 2.75 | 7.29 5 | 16 Good
3M Return % 11.43 6.59 8.48 4.58 | 11.59 3 | 16 Very Good
6M Return % 6.28 4.11 1.08 -2.08 | 6.28 1 | 16 Very Good
1Y Return % 14.20 6.53 7.52 3.04 | 14.20 1 | 15 Very Good
1Y SIP Return % 15.81 6.88 -11.58 | 15.81 1 | 15 Very Good
Return data last Updated On : April 27, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
27-04-2026 18.267 18.839
24-04-2026 17.854 18.41
23-04-2026 18.028 18.589
22-04-2026 17.895 18.452
21-04-2026 17.823 18.377
20-04-2026 17.811 18.364
17-04-2026 17.812 18.363
16-04-2026 17.743 18.292
15-04-2026 17.731 18.279
13-04-2026 17.414 17.951
10-04-2026 17.502 18.04
09-04-2026 17.386 17.92
08-04-2026 17.222 17.75
07-04-2026 16.92 17.439
06-04-2026 16.854 17.37
02-04-2026 16.758 17.269
01-04-2026 16.931 17.446
30-03-2026 16.979 17.495
27-03-2026 17.191 17.711

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.